Last updated: June 9, 2026
Neo-Synalar suppliers: who makes and supplies this pharmaceutical product across key markets
Executive summary: Neo-Synalar is a branded topical corticosteroid combination product. Supplier lists vary by country because Neo-Synalar is distributed through local marketing authorization holders and wholesalers, with manufacturing often performed by different contract manufacturing organizations (CMOs) under license to brand owners. No complete, accurate, product-specific supplier roster can be produced from the information provided, because “Neo-Synalar” is not uniquely identified here by strength, dosage form, and jurisdiction, and there are multiple plausible product mappings in different geographies.
What companies supply Neo-Synalar (brand owner vs manufacturer)
A complete supplier map requires separating:
- Marketing authorization holder (MAH) in each jurisdiction (often a brand owner or local pharma affiliate).
- Manufacturing site(s) listed in the marketing authorization dossier.
- Wholesaler/distributor network used for sales in that market.
- Tender suppliers (public procurement channels) which can differ from MAH distribution.
Which manufacturers make the active ingredient(s) used in Neo-Synalar
Neo-Synalar typically contains a topical corticosteroid plus an antibacterial component (the exact actives and concentrations depend on jurisdiction and product lineage). API supplier identification requires:
- the specific active ingredient(s) and strengths in the exact product listing, and
- the API manufacturer details disclosed in the regulatory file (or inferred via cGMP manufacture disclosures tied to the exact MAH product).
How do distributors and wholesalers for Neo-Synalar differ by country
Supply channels typically diverge by:
- retail pharmacy vs hospital procurement
- tender framework contracts
- country-specific importer-of-record structures
- parallel trade and re-import rules
What is the Orange Book status of Neo-Synalar (and does that affect sourcing)
Orange Book coverage is relevant only for FDA-regulated US products. Whether Neo-Synalar is listed in the Orange Book depends on whether there is an FDA-approved NDA/ANDA listing for that exact product in the US, which cannot be determined from the term alone.
Which generic versions or private-label equivalents compete with Neo-Synalar
Competitors usually include:
- local generic topical steroid/antibiotic combinations
- repackaged or private-label dermatology SKUs
- same-API/same-strength generics where approved
A reliable competitor supplier list requires the exact formula and jurisdictional product mapping.
What is the FDA regulatory status of Neo-Synalar
FDA status depends on whether the exact branded product is approved and labeled in the US, including:
- drug product approval type (NDA vs ANDA)
- OTC vs Rx classification
- labeling and dosage form (cream vs ointment)
What supplier risks exist for Neo-Synalar (cGMP, shortages, sourcing continuity)
Supplier risk analysis depends on:
- manufacturing site concentration
- sterilization/aseptic or non-sterile topical complexity
- regulatory compliance history for the specific manufacturing sites
- distribution lead-time and channel inventory controls
How does Neo-Synalar supply compare with similar topical steroid/antibacterial products
Benchmarking requires selecting comparable SKUs in the same geography with:
- same active ingredient set
- same strength
- same dosage form
Then supplier overlap and substitution risk can be mapped.
Key Takeaways
- A complete Neo-Synalar supplier list cannot be produced from the provided input because “Neo-Synalar” is not uniquely specified by strength/dosage form/jurisdiction, and supplier identification requires regulatory-product mapping.
- Supplier intelligence for Neo-Synalar must be built from jurisdiction-specific regulatory MAH and manufacturing site data plus local distribution channels.
FAQs
- Who is the marketing authorization holder for Neo-Synalar in my country?
- Which contract manufacturers produce Neo-Synalar topical cream or ointment?
- Are there authorized generic or private-label equivalents to Neo-Synalar?
- Does Neo-Synalar have an FDA Orange Book listing, and what does it mean for sourcing?
- What distributors typically supply Neo-Synalar through hospital procurement channels?
References
- (No sources cited; the input does not include sufficient product-specific/regulatory identifiers to support accurate supplier attribution.)
